Telmira Tablet 40 mg (Telmisartan)

Adult dose

For essential hypertension, the recommended dose is 40 mg of telmisartan taken orally once daily with water, and it can be taken regardless of meals. Depending on the patient, 20 mg once daily may be effective, and if necessary, the dose can be increased up to 80 mg once daily. The maximum blood pressure-lowering effect is observed 4 to 8 weeks after starting treatment. For the reduction of cardiovascular disease risk, 80 mg once daily with water is recommended.

This drug may cause serious harm, especially to the fetus and newborn, during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with a known allergy to this drug, those who are pregnant or breastfeeding, those with severely impaired liver function, or those with a history of hereditary angioedema should not take this medication. Patients with mild liver impairment, elderly patients, those with hyperkalemia, and those with heart or kidney diseases should use this drug cautiously and should have their conditions monitored regularly by a physician. During treatment, blood pressure, kidney function, and blood potassium levels should be monitored regularly for any abnormalities. When combined with other antihypertensive medications, there may be an increased risk of hypotension, worsening kidney function, and hyperkalemia, so consultation with a physician is necessary. If blood pressure drops too low or symptoms of dizziness or fainting occur, immediate medical attention must be sought for appropriate treatment. This drug contains sorbitol and is unsuitable for patients with fructose intolerance. Caution is needed when driving or operating machinery as dizziness or fainting may occur. In case of overdose, symptoms such as hypotension, abnormal heart rate, and worsening kidney function may arise, necessitating an immediate visit to a medical facility. It is not recommended for children and adolescents under 18 years due to insufficient evidence of safety and efficacy. Store out of reach of children and do not transfer to other containers during treatment.

Serious side effects

Hives, severe swelling (angioedema, facial swelling, laryngeal edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, oral/ocular mucosal pain, dyspnea, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis

Mild side effects

• Upper respiratory tract infections
• pharyngitis
• sinusitis
• urinary tract infections
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication may be sensitive to air or moisture, so it should be stored in a closed container. Additionally, it is best to store the medication at room temperature between 1 degree and 30 degrees Celsius, avoiding extremely hot or cold locations.

Appearance

White or off-white, convex oval tablet

Package unit

30 tablets/bottle, 100 tablets/bottle